0000950170-24-034198.txt : 20240320
0000950170-24-034198.hdr.sgml : 20240320
20240320162811
ACCESSION NUMBER: 0000950170-24-034198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240319
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GKCC, LLC
CENTRAL INDEX KEY: 0001977769
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 24768131
BUSINESS ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
BUSINESS PHONE: (302) 992-8882
MAIL ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chudnovsky Yekaterina
CENTRAL INDEX KEY: 0001979324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 24768132
MAIL ADDRESS:
STREET 1: C/O ELICIO THERAPEUTICS, INC.
STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
ownership.xml
4
X0508
4
2024-03-19
0001601485
Elicio Therapeutics, Inc.
ELTX
0001979324
Chudnovsky Yekaterina
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR, SUITE 501
BOSTON
MA
02210
true
false
true
false
0001977769
GKCC, LLC
501 SILVERSIDE ROAD, SUITE 87AVA
WILMINGTON
DE
19809
false
false
true
false
false
Pre-Funded Common Stock Purchase Warrant
0.01
2024-03-19
4
P
false
1032702
5.81
A
Common Stock
1032702
1032702
I
Held by GKCC, LLC
Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained.
The Pre-Funded Warrants do not have an expiration date.
Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
/s/ Yekaterina Chudnovsky
2024-03-20
/s/ Yekaterina Chudnovsky, Manager of GKCC, LLC
2024-03-20